Stay updated on Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial
Sign up to get notified when there's something new on the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page.

Latest updates to the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2; no observable changes to study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check33 days agoChange DetectedThe changes are UI-related (glossary show/hide) and include metadata updates such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a new revision version (v3.4.0). To avoid alerting on small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check40 days agoChange DetectedThe page's revision metadata updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedAdded a Locations section including Maryland as a location and updated the page revision to v3.3.3. Removed the Maryland Locations section and the HHS Vulnerability Disclosure.SummaryDifference0.2%

- Check90 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page.